nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.0718	0.12	CcSEcCtD
Ondansetron—Warmth—Liotrix—hypothyroidism	0.0291	0.0488	CcSEcCtD
Ondansetron—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.026	0.0435	CcSEcCtD
Ondansetron—HTR4—adrenal cortex—hypothyroidism	0.0222	0.0783	CbGeAlD
Ondansetron—HTR4—pituitary gland—hypothyroidism	0.018	0.0632	CbGeAlD
Ondansetron—HTR4—adrenal gland—hypothyroidism	0.016	0.0565	CbGeAlD
Ondansetron—Angina pectoris—Liothyronine—hypothyroidism	0.0157	0.0263	CcSEcCtD
Ondansetron—HTR3A—nerve—hypothyroidism	0.0156	0.055	CbGeAlD
Ondansetron—OPRM1—nerve—hypothyroidism	0.0143	0.0505	CbGeAlD
Ondansetron—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0141	0.0237	CcSEcCtD
Ondansetron—Myocardial infarction—Liothyronine—hypothyroidism	0.0141	0.0236	CcSEcCtD
Ondansetron—Feeling hot—Liotrix—hypothyroidism	0.0118	0.0198	CcSEcCtD
Ondansetron—CYP1A2—urine—hypothyroidism	0.0117	0.0412	CbGeAlD
Ondansetron—Arrhythmia—Liothyronine—hypothyroidism	0.0115	0.0193	CcSEcCtD
Ondansetron—CYP2C9—urine—hypothyroidism	0.0111	0.0391	CbGeAlD
Ondansetron—CYP2E1—urine—hypothyroidism	0.0105	0.037	CbGeAlD
Ondansetron—Tachycardia—Liothyronine—hypothyroidism	0.00893	0.015	CcSEcCtD
Ondansetron—Hypotension—Liothyronine—hypothyroidism	0.00855	0.0143	CcSEcCtD
Ondansetron—CYP3A4—urine—hypothyroidism	0.00846	0.0298	CbGeAlD
Ondansetron—CYP2D6—urine—hypothyroidism	0.00833	0.0293	CbGeAlD
Ondansetron—Angina pectoris—Levothyroxine—hypothyroidism	0.0077	0.0129	CcSEcCtD
Ondansetron—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0077	0.0129	CcSEcCtD
Ondansetron—Swelling—Liotrix—hypothyroidism	0.00763	0.0128	CcSEcCtD
Ondansetron—Body temperature increased—Liothyronine—hypothyroidism	0.00724	0.0121	CcSEcCtD
Ondansetron—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00695	0.0116	CcSEcCtD
Ondansetron—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00695	0.0116	CcSEcCtD
Ondansetron—Myocardial infarction—Levothyroxine—hypothyroidism	0.00691	0.0116	CcSEcCtD
Ondansetron—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00691	0.0116	CcSEcCtD
Ondansetron—KCNH2—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.00666	0.0561	CbGpPWpGaD
Ondansetron—Hypokalaemia—Liotrix—hypothyroidism	0.00612	0.0103	CcSEcCtD
Ondansetron—SLC47A1—adrenal cortex—hypothyroidism	0.0059	0.0208	CbGeAlD
Ondansetron—Flushing—Dextrothyroxine—hypothyroidism	0.00587	0.00983	CcSEcCtD
Ondansetron—Flushing—Levothyroxine—hypothyroidism	0.00587	0.00983	CcSEcCtD
Ondansetron—Bronchospasm—Liotrix—hypothyroidism	0.00572	0.00958	CcSEcCtD
Ondansetron—SLC47A1—heart—hypothyroidism	0.0057	0.0201	CbGeAlD
Ondansetron—Angina pectoris—Liotrix—hypothyroidism	0.00566	0.00949	CcSEcCtD
Ondansetron—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00565	0.00947	CcSEcCtD
Ondansetron—Arrhythmia—Levothyroxine—hypothyroidism	0.00565	0.00947	CcSEcCtD
Ondansetron—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00541	0.0455	CbGpPWpGaD
Ondansetron—Tremor—Dextrothyroxine—hypothyroidism	0.00516	0.00864	CcSEcCtD
Ondansetron—Tremor—Levothyroxine—hypothyroidism	0.00516	0.00864	CcSEcCtD
Ondansetron—Acute coronary syndrome—Liotrix—hypothyroidism	0.00511	0.00856	CcSEcCtD
Ondansetron—Myocardial infarction—Liotrix—hypothyroidism	0.00508	0.00851	CcSEcCtD
Ondansetron—Agitation—Levothyroxine—hypothyroidism	0.00506	0.00848	CcSEcCtD
Ondansetron—Agitation—Dextrothyroxine—hypothyroidism	0.00506	0.00848	CcSEcCtD
Ondansetron—Angioedema—Levothyroxine—hypothyroidism	0.00503	0.00843	CcSEcCtD
Ondansetron—Angioedema—Dextrothyroxine—hypothyroidism	0.00503	0.00843	CcSEcCtD
Ondansetron—SLC47A1—gonad—hypothyroidism	0.00488	0.0172	CbGeAlD
Ondansetron—Palpitations—Levothyroxine—hypothyroidism	0.00487	0.00815	CcSEcCtD
Ondansetron—Palpitations—Dextrothyroxine—hypothyroidism	0.00487	0.00815	CcSEcCtD
Ondansetron—CYP3A7—liver—hypothyroidism	0.00479	0.0169	CbGeAlD
Ondansetron—Convulsion—Dextrothyroxine—hypothyroidism	0.00477	0.00799	CcSEcCtD
Ondansetron—Convulsion—Levothyroxine—hypothyroidism	0.00477	0.00799	CcSEcCtD
Ondansetron—SLC47A1—pituitary gland—hypothyroidism	0.00476	0.0168	CbGeAlD
Ondansetron—Anxiety—Dextrothyroxine—hypothyroidism	0.00467	0.00783	CcSEcCtD
Ondansetron—Anxiety—Levothyroxine—hypothyroidism	0.00467	0.00783	CcSEcCtD
Ondansetron—HTR1B—cardiovascular system—hypothyroidism	0.0046	0.0162	CbGeAlD
Ondansetron—Shock—Levothyroxine—hypothyroidism	0.00442	0.00741	CcSEcCtD
Ondansetron—Shock—Dextrothyroxine—hypothyroidism	0.00442	0.00741	CcSEcCtD
Ondansetron—Tachycardia—Dextrothyroxine—hypothyroidism	0.00439	0.00735	CcSEcCtD
Ondansetron—Tachycardia—Levothyroxine—hypothyroidism	0.00439	0.00735	CcSEcCtD
Ondansetron—HTR3A—blood—hypothyroidism	0.00433	0.0153	CbGeAlD
Ondansetron—Flushing—Liotrix—hypothyroidism	0.00432	0.00723	CcSEcCtD
Ondansetron—SLC47A1—adrenal gland—hypothyroidism	0.00426	0.015	CbGeAlD
Ondansetron—SLC47A1—blood—hypothyroidism	0.00426	0.015	CbGeAlD
Ondansetron—Arrhythmia—Liotrix—hypothyroidism	0.00416	0.00696	CcSEcCtD
Ondansetron—SLC47A1—thyroid gland—hypothyroidism	0.00411	0.0145	CbGeAlD
Ondansetron—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00407	0.0143	CbGeAlD
Ondansetron—Dyspnoea—Levothyroxine—hypothyroidism	0.00401	0.00671	CcSEcCtD
Ondansetron—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00401	0.00671	CcSEcCtD
Ondansetron—Flatulence—Liotrix—hypothyroidism	0.00399	0.00669	CcSEcCtD
Ondansetron—OPRM1—blood—hypothyroidism	0.00397	0.014	CbGeAlD
Ondansetron—SLC47A1—female gonad—hypothyroidism	0.00397	0.014	CbGeAlD
Ondansetron—Fatigue—Levothyroxine—hypothyroidism	0.00388	0.00649	CcSEcCtD
Ondansetron—Fatigue—Dextrothyroxine—hypothyroidism	0.00388	0.00649	CcSEcCtD
Ondansetron—Vision blurred—Liotrix—hypothyroidism	0.00382	0.00639	CcSEcCtD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00382	0.0321	CbGpPWpGaD
Ondansetron—Tremor—Liotrix—hypothyroidism	0.0038	0.00636	CcSEcCtD
Ondansetron—Agitation—Liotrix—hypothyroidism	0.00372	0.00624	CcSEcCtD
Ondansetron—HTR1A—cardiovascular system—hypothyroidism	0.00371	0.0131	CbGeAlD
Ondansetron—Feeling abnormal—Levothyroxine—hypothyroidism	0.0037	0.0062	CcSEcCtD
Ondansetron—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.0037	0.0062	CcSEcCtD
Ondansetron—Angioedema—Liotrix—hypothyroidism	0.0037	0.0062	CcSEcCtD
Ondansetron—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00368	0.00616	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00368	0.00616	CcSEcCtD
Ondansetron—Syncope—Liotrix—hypothyroidism	0.00363	0.00608	CcSEcCtD
Ondansetron—Palpitations—Liotrix—hypothyroidism	0.00358	0.006	CcSEcCtD
Ondansetron—Urticaria—Dextrothyroxine—hypothyroidism	0.00357	0.00598	CcSEcCtD
Ondansetron—Urticaria—Levothyroxine—hypothyroidism	0.00357	0.00598	CcSEcCtD
Ondansetron—Loss of consciousness—Liotrix—hypothyroidism	0.00356	0.00596	CcSEcCtD
Ondansetron—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00355	0.00595	CcSEcCtD
Ondansetron—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00355	0.00595	CcSEcCtD
Ondansetron—Body temperature increased—Levothyroxine—hypothyroidism	0.00355	0.00595	CcSEcCtD
Ondansetron—Abdominal pain—Levothyroxine—hypothyroidism	0.00355	0.00595	CcSEcCtD
Ondansetron—SLC47A1—testis—hypothyroidism	0.00352	0.0124	CbGeAlD
Ondansetron—Convulsion—Liotrix—hypothyroidism	0.00351	0.00588	CcSEcCtD
Ondansetron—KCNH2—heart—hypothyroidism	0.0035	0.0123	CbGeAlD
Ondansetron—Chest pain—Liotrix—hypothyroidism	0.00345	0.00578	CcSEcCtD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00344	0.029	CbGpPWpGaD
Ondansetron—Anxiety—Liotrix—hypothyroidism	0.00344	0.00576	CcSEcCtD
Ondansetron—SLC47A1—liver—hypothyroidism	0.00333	0.0117	CbGeAlD
Ondansetron—Anaphylactic shock—Liotrix—hypothyroidism	0.00331	0.00554	CcSEcCtD
Ondansetron—KCNH2—cardiovascular system—hypothyroidism	0.0033	0.0116	CbGeAlD
Ondansetron—OPRM1—testis—hypothyroidism	0.00328	0.0116	CbGeAlD
Ondansetron—Shock—Liotrix—hypothyroidism	0.00325	0.00545	CcSEcCtD
Ondansetron—SLC47A1—cerebellum—hypothyroidism	0.00325	0.0114	CbGeAlD
Ondansetron—Tachycardia—Liotrix—hypothyroidism	0.00323	0.0054	CcSEcCtD
Ondansetron—Asthenia—Dextrothyroxine—hypothyroidism	0.00323	0.0054	CcSEcCtD
Ondansetron—Asthenia—Levothyroxine—hypothyroidism	0.00323	0.0054	CcSEcCtD
Ondansetron—Pruritus—Levothyroxine—hypothyroidism	0.00318	0.00533	CcSEcCtD
Ondansetron—Pruritus—Dextrothyroxine—hypothyroidism	0.00318	0.00533	CcSEcCtD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00316	0.0266	CbGpPWpGaD
Ondansetron—Hypotension—Liotrix—hypothyroidism	0.00309	0.00517	CcSEcCtD
Ondansetron—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00308	0.00515	CcSEcCtD
Ondansetron—Diarrhoea—Levothyroxine—hypothyroidism	0.00308	0.00515	CcSEcCtD
Ondansetron—Paraesthesia—Liotrix—hypothyroidism	0.00297	0.00497	CcSEcCtD
Ondansetron—Dyspnoea—Liotrix—hypothyroidism	0.00295	0.00494	CcSEcCtD
Ondansetron—HTR1A—adrenal gland—hypothyroidism	0.00293	0.0103	CbGeAlD
Ondansetron—KCNH2—pituitary gland—hypothyroidism	0.00292	0.0103	CbGeAlD
Ondansetron—Vomiting—Dextrothyroxine—hypothyroidism	0.00286	0.00479	CcSEcCtD
Ondansetron—Vomiting—Levothyroxine—hypothyroidism	0.00286	0.00479	CcSEcCtD
Ondansetron—Fatigue—Liotrix—hypothyroidism	0.00285	0.00477	CcSEcCtD
Ondansetron—CYP2C9—heart—hypothyroidism	0.00284	0.01	CbGeAlD
Ondansetron—Rash—Levothyroxine—hypothyroidism	0.00283	0.00475	CcSEcCtD
Ondansetron—Rash—Dextrothyroxine—hypothyroidism	0.00283	0.00475	CcSEcCtD
Ondansetron—Dermatitis—Levothyroxine—hypothyroidism	0.00283	0.00474	CcSEcCtD
Ondansetron—Dermatitis—Dextrothyroxine—hypothyroidism	0.00283	0.00474	CcSEcCtD
Ondansetron—Constipation—Liotrix—hypothyroidism	0.00283	0.00474	CcSEcCtD
Ondansetron—Headache—Dextrothyroxine—hypothyroidism	0.00282	0.00472	CcSEcCtD
Ondansetron—Headache—Levothyroxine—hypothyroidism	0.00282	0.00472	CcSEcCtD
Ondansetron—Feeling abnormal—Liotrix—hypothyroidism	0.00273	0.00456	CcSEcCtD
Ondansetron—Gastrointestinal pain—Liotrix—hypothyroidism	0.0027	0.00453	CcSEcCtD
Ondansetron—CYP2C9—cardiovascular system—hypothyroidism	0.00268	0.00945	CbGeAlD
Ondansetron—Urticaria—Liotrix—hypothyroidism	0.00263	0.0044	CcSEcCtD
Ondansetron—Body temperature increased—Liotrix—hypothyroidism	0.00261	0.00438	CcSEcCtD
Ondansetron—Abdominal pain—Liotrix—hypothyroidism	0.00261	0.00438	CcSEcCtD
Ondansetron—KCNH2—adrenal gland—hypothyroidism	0.00261	0.00919	CbGeAlD
Ondansetron—KCNH2—blood—hypothyroidism	0.00261	0.00919	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—hypothyroidism	0.00254	0.00895	CbGeAlD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00246	0.0207	CbGpPWpGaD
Ondansetron—HTR4—G alpha (s) signalling events—TSHB—hypothyroidism	0.00246	0.0207	CbGpPWpGaD
Ondansetron—HTR4—G alpha (s) signalling events—TSHR—hypothyroidism	0.00246	0.0207	CbGpPWpGaD
Ondansetron—Hypersensitivity—Liotrix—hypothyroidism	0.00244	0.00408	CcSEcCtD
Ondansetron—KCNH2—female gonad—hypothyroidism	0.00243	0.00857	CbGeAlD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00238	0.0201	CbGpPWpGaD
Ondansetron—Asthenia—Liotrix—hypothyroidism	0.00237	0.00397	CcSEcCtD
Ondansetron—Pruritus—Liotrix—hypothyroidism	0.00234	0.00392	CcSEcCtD
Ondansetron—Diarrhoea—Liotrix—hypothyroidism	0.00226	0.00379	CcSEcCtD
Ondansetron—HTR1A—cerebellum—hypothyroidism	0.00224	0.00789	CbGeAlD
Ondansetron—CYP1A2—blood—hypothyroidism	0.00224	0.00787	CbGeAlD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00222	0.0187	CbGpPWpGaD
Ondansetron—Dizziness—Liotrix—hypothyroidism	0.00219	0.00366	CcSEcCtD
Ondansetron—KCNH2—testis—hypothyroidism	0.00216	0.0076	CbGeAlD
Ondansetron—CYP1A2—thyroid gland—hypothyroidism	0.00216	0.0076	CbGeAlD
Ondansetron—CYP3A5—blood—hypothyroidism	0.00216	0.00759	CbGeAlD
Ondansetron—CYP2C9—blood—hypothyroidism	0.00212	0.00747	CbGeAlD
Ondansetron—Vomiting—Liotrix—hypothyroidism	0.0021	0.00352	CcSEcCtD
Ondansetron—Rash—Liotrix—hypothyroidism	0.00209	0.00349	CcSEcCtD
Ondansetron—Dermatitis—Liotrix—hypothyroidism	0.00208	0.00349	CcSEcCtD
Ondansetron—Headache—Liotrix—hypothyroidism	0.00207	0.00347	CcSEcCtD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00204	0.0172	CbGpPWpGaD
Ondansetron—CYP2E1—adrenal gland—hypothyroidism	0.00201	0.00708	CbGeAlD
Ondansetron—CYP2E1—blood—hypothyroidism	0.00201	0.00708	CbGeAlD
Ondansetron—CYP3A5—female gonad—hypothyroidism	0.00201	0.00708	CbGeAlD
Ondansetron—KCNH2—cerebellum—hypothyroidism	0.00199	0.00702	CbGeAlD
Ondansetron—CYP2E1—thyroid gland—hypothyroidism	0.00194	0.00683	CbGeAlD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00194	0.0163	CbGpPWpGaD
Ondansetron—CYP1A2—liver—hypothyroidism	0.00175	0.00615	CbGeAlD
Ondansetron—CYP3A5—liver—hypothyroidism	0.00169	0.00594	CbGeAlD
Ondansetron—CYP2E1—testis—hypothyroidism	0.00166	0.00586	CbGeAlD
Ondansetron—CYP2C9—liver—hypothyroidism	0.00166	0.00584	CbGeAlD
Ondansetron—CYP3A4—blood—hypothyroidism	0.00162	0.0057	CbGeAlD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00161	0.0135	CbGpPWpGaD
Ondansetron—CYP2D6—blood—hypothyroidism	0.00159	0.00561	CbGeAlD
Ondansetron—CYP2E1—liver—hypothyroidism	0.00157	0.00554	CbGeAlD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00154	0.0129	CbGpPWpGaD
Ondansetron—CYP2E1—cerebellum—hypothyroidism	0.00154	0.00541	CbGeAlD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00153	0.0128	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0015	0.0126	CbGpPWpGaD
Ondansetron—CYP2D6—female gonad—hypothyroidism	0.00148	0.00523	CbGeAlD
Ondansetron—HTR4—G alpha (s) signalling events—AVP—hypothyroidism	0.00145	0.0122	CbGpPWpGaD
Ondansetron—OPRM1—Peptide GPCRs—TSHR—hypothyroidism	0.00137	0.0115	CbGpPWpGaD
Ondansetron—CYP2D6—testis—hypothyroidism	0.00132	0.00464	CbGeAlD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00131	0.0111	CbGpPWpGaD
Ondansetron—CYP3A4—liver—hypothyroidism	0.00127	0.00445	CbGeAlD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00125	0.0105	CbGpPWpGaD
Ondansetron—CYP2D6—liver—hypothyroidism	0.00125	0.00438	CbGeAlD
Ondansetron—KCNH2—Neuronal System—SLC5A7—hypothyroidism	0.00122	0.0103	CbGpPWpGaD
Ondansetron—CYP2D6—cerebellum—hypothyroidism	0.00122	0.00428	CbGeAlD
Ondansetron—OPRM1—G-protein activation—POMC—hypothyroidism	0.0012	0.0101	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.0012	0.0101	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00117	0.00986	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00117	0.00986	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—SH2B3—hypothyroidism	0.00104	0.00879	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00104	0.00872	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—TRH—hypothyroidism	0.001	0.00843	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000983	0.00827	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000964	0.00811	CbGpPWpGaD
Ondansetron—HTR4—G alpha (s) signalling events—POMC—hypothyroidism	0.000963	0.0081	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000947	0.00797	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—TSHB—hypothyroidism	0.000892	0.00751	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—TSHR—hypothyroidism	0.000892	0.00751	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000882	0.00743	CbGpPWpGaD
Ondansetron—KCNH2—Neuronal System—NEFL—hypothyroidism	0.000787	0.00662	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000785	0.0066	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000775	0.00652	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000774	0.00651	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000723	0.00608	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—VAV3—hypothyroidism	0.000716	0.00603	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000691	0.00581	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000612	0.00515	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00061	0.00514	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—TRH—hypothyroidism	0.000566	0.00476	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000549	0.00462	CbGpPWpGaD
Ondansetron—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000546	0.00459	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—AVP—hypothyroidism	0.000526	0.00443	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—TRH—hypothyroidism	0.000514	0.00433	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—TSHB—hypothyroidism	0.000504	0.00425	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—TSHR—hypothyroidism	0.000504	0.00425	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000499	0.0042	CbGpPWpGaD
Ondansetron—OPRM1—Opioid Signalling—POMC—hypothyroidism	0.000499	0.0042	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00049	0.00412	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00049	0.00412	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000485	0.00408	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000459	0.00386	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—TSHB—hypothyroidism	0.000458	0.00386	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—TSHR—hypothyroidism	0.000458	0.00386	CbGpPWpGaD
Ondansetron—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000442	0.00372	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000432	0.00364	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000432	0.00364	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000418	0.00352	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—TRH—hypothyroidism	0.000418	0.00352	CbGpPWpGaD
Ondansetron—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000395	0.00333	CbGpPWpGaD
Ondansetron—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000394	0.00332	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000393	0.00331	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000384	0.00323	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00038	0.0032	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000379	0.00319	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—TSHB—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—TSHR—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—TRH—hypothyroidism	0.000369	0.00311	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CLTC—hypothyroidism	0.000351	0.00296	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—POMC—hypothyroidism	0.00035	0.00294	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000329	0.00277	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000329	0.00277	CbGpPWpGaD
Ondansetron—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00032	0.0027	CbGpPWpGaD
Ondansetron—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00032	0.00269	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—TRH—hypothyroidism	0.000319	0.00268	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—VAV3—hypothyroidism	0.000309	0.0026	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TRH—hypothyroidism	0.000304	0.00256	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000298	0.00251	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—AVP—hypothyroidism	0.000297	0.0025	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000289	0.00243	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—TSHB—hypothyroidism	0.000284	0.00239	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—TSHR—hypothyroidism	0.000284	0.00239	CbGpPWpGaD
Ondansetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00028	0.00236	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—VAV3—hypothyroidism	0.00028	0.00236	CbGpPWpGaD
Ondansetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000278	0.00234	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—IYD—hypothyroidism	0.000277	0.00233	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TSHB—hypothyroidism	0.000271	0.00228	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TSHR—hypothyroidism	0.000271	0.00228	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—AVP—hypothyroidism	0.00027	0.00227	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000255	0.00214	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000252	0.00212	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—POMC—hypothyroidism	0.000241	0.00203	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SH2B3—hypothyroidism	0.000241	0.00203	CbGpPWpGaD
Ondansetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000238	0.002	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TRH—hypothyroidism	0.000236	0.00199	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ATP5O—hypothyroidism	0.000236	0.00198	CbGpPWpGaD
Ondansetron—CYP3A7—Biological oxidations—POMC—hypothyroidism	0.000235	0.00198	CbGpPWpGaD
Ondansetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000227	0.00191	CbGpPWpGaD
Ondansetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000225	0.0019	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—TPO—hypothyroidism	0.000222	0.00187	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00022	0.00185	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—AVP—hypothyroidism	0.00022	0.00185	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TRH—hypothyroidism	0.000215	0.00181	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	0.000213	0.00179	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TSHB—hypothyroidism	0.000211	0.00177	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TSHR—hypothyroidism	0.000211	0.00177	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000209	0.00176	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—IYD—hypothyroidism	0.000201	0.00169	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—IYD—hypothyroidism	0.0002	0.00169	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—POMC—hypothyroidism	0.000198	0.00166	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—AVP—hypothyroidism	0.000194	0.00163	CbGpPWpGaD
Ondansetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000193	0.00162	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000192	0.00161	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TSHB—hypothyroidism	0.000191	0.00161	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TSHR—hypothyroidism	0.000191	0.00161	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TRH—hypothyroidism	0.000189	0.00159	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000186	0.00157	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000186	0.00157	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—POMC—hypothyroidism	0.000184	0.00155	CbGpPWpGaD
Ondansetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000183	0.00154	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TRH—hypothyroidism	0.00018	0.00152	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—POMC—hypothyroidism	0.000179	0.00151	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PRL—hypothyroidism	0.000179	0.00151	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000171	0.00144	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.00017	0.00143	CbGpPWpGaD
Ondansetron—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.00017	0.00143	CbGpPWpGaD
Ondansetron—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.00017	0.00143	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000169	0.00142	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000169	0.00142	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000169	0.00142	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—AVP—hypothyroidism	0.000167	0.00141	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—VAV3—hypothyroidism	0.000166	0.00139	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TRH—hypothyroidism	0.000164	0.00138	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TPO—hypothyroidism	0.000161	0.00135	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000161	0.00135	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000161	0.00135	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TPO—hypothyroidism	0.00016	0.00135	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—AVP—hypothyroidism	0.000159	0.00134	CbGpPWpGaD
Ondansetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000149	0.00125	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CLTC—hypothyroidism	0.000147	0.00124	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000146	0.00123	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—POMC—hypothyroidism	0.000146	0.00123	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TSHR—hypothyroidism	0.000146	0.00123	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TSHB—hypothyroidism	0.000146	0.00123	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—IYD—hypothyroidism	0.000143	0.0012	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—IYD—hypothyroidism	0.000141	0.00119	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CLTC—hypothyroidism	0.000129	0.00109	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—VAV3—hypothyroidism	0.000129	0.00108	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—POMC—hypothyroidism	0.000129	0.00108	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TRH—hypothyroidism	0.000127	0.00107	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AVP—hypothyroidism	0.000124	0.00105	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000121	0.00102	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000121	0.00102	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—IYD—hypothyroidism	0.000121	0.00102	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.00012	0.00101	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.00012	0.00101	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—VAV3—hypothyroidism	0.000117	0.000985	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TPO—hypothyroidism	0.000114	0.000959	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	0.000114	0.000958	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TSHB—hypothyroidism	0.000113	0.000951	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TSHR—hypothyroidism	0.000113	0.000951	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TPO—hypothyroidism	0.000113	0.000951	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AVP—hypothyroidism	0.000113	0.000949	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TRH—hypothyroidism	0.000112	0.000942	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CLTC—hypothyroidism	0.000112	0.000941	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—POMC—hypothyroidism	0.000111	0.000936	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	0.00011	0.000923	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—POMC—hypothyroidism	0.000106	0.000892	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000105	0.000881	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	0.000103	0.00087	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ATP5O—hypothyroidism	0.000103	0.000864	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—TSHB—hypothyroidism	0.000103	0.000864	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—POMC—hypothyroidism	0.000102	0.000861	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IGF1—hypothyroidism	0.000102	0.000858	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SH2B3—hypothyroidism	0.000101	0.000848	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TSHB—hypothyroidism	9.98e-05	0.00084	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TSHR—hypothyroidism	9.98e-05	0.00084	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AVP—hypothyroidism	9.95e-05	0.000838	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	9.82e-05	0.000826	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TRH—hypothyroidism	9.66e-05	0.000813	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TPO—hypothyroidism	9.65e-05	0.000812	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	9.46e-05	0.000796	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—IYD—hypothyroidism	9.32e-05	0.000784	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	9.15e-05	0.00077	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.94e-05	0.000753	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	8.92e-05	0.000751	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	8.89e-05	0.000748	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TSHB—hypothyroidism	8.61e-05	0.000725	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TSHR—hypothyroidism	8.61e-05	0.000725	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AVP—hypothyroidism	8.59e-05	0.000723	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	8.25e-05	0.000695	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ATP5O—hypothyroidism	7.92e-05	0.000667	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—hypothyroidism	7.9e-05	0.000665	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC5A5—hypothyroidism	7.68e-05	0.000647	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	7.67e-05	0.000646	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—hypothyroidism	7.49e-05	0.000631	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PRL—hypothyroidism	7.47e-05	0.000629	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TPO—hypothyroidism	7.45e-05	0.000627	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TSHB—hypothyroidism	7.43e-05	0.000626	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TSHB—hypothyroidism	7.42e-05	0.000624	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	7.28e-05	0.000613	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VAV3—hypothyroidism	6.91e-05	0.000582	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AVP—hypothyroidism	6.66e-05	0.000561	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	6.62e-05	0.000558	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—hypothyroidism	6.61e-05	0.000557	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	6.61e-05	0.000556	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PRL—hypothyroidism	6.6e-05	0.000555	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	6.29e-05	0.000529	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VAV3—hypothyroidism	6.1e-05	0.000514	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AVP—hypothyroidism	5.88e-05	0.000495	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—hypothyroidism	5.71e-05	0.000481	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PRL—hypothyroidism	5.69e-05	0.000479	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC5A5—hypothyroidism	5.56e-05	0.000468	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC5A5—hypothyroidism	5.55e-05	0.000467	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TSHB—hypothyroidism	5.27e-05	0.000444	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VAV3—hypothyroidism	5.27e-05	0.000443	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TSHB—hypothyroidism	5.23e-05	0.00044	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AVP—hypothyroidism	5.07e-05	0.000427	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.7e-05	0.000396	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	4.66e-05	0.000392	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.6e-05	0.000387	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TSHB—hypothyroidism	4.47e-05	0.000376	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—hypothyroidism	4.43e-05	0.000373	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF1—hypothyroidism	4.26e-05	0.000358	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—hypothyroidism	4.02e-05	0.000338	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	3.98e-05	0.000335	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.95e-05	0.000332	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.93e-05	0.000331	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC5A5—hypothyroidism	3.91e-05	0.000329	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—hypothyroidism	3.91e-05	0.000329	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1—hypothyroidism	3.76e-05	0.000316	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TSHB—hypothyroidism	3.45e-05	0.00029	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—hypothyroidism	3.37e-05	0.000284	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC5A5—hypothyroidism	3.34e-05	0.000282	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—hypothyroidism	3.24e-05	0.000273	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.07e-05	0.000259	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—hypothyroidism	2.91e-05	0.000245	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—hypothyroidism	2.9e-05	0.000245	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.58e-05	0.000217	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—hypothyroidism	2.07e-05	0.000174	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—hypothyroidism	2.05e-05	0.000172	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—hypothyroidism	1.75e-05	0.000147	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—hypothyroidism	1.35e-05	0.000114	CbGpPWpGaD
